Nothing Special   »   [go: up one dir, main page]

FI900035A - Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI900035A
FI900035A FI900035A FI900035A FI900035A FI 900035 A FI900035 A FI 900035A FI 900035 A FI900035 A FI 900035A FI 900035 A FI900035 A FI 900035A FI 900035 A FI900035 A FI 900035A
Authority
FI
Finland
Prior art keywords
tiazolfoereningar
foerfarande foer
deras framstaellning
framstaellning och
foer deras
Prior art date
Application number
FI900035A
Other languages
English (en)
Other versions
FI900035A0 (fi
Inventor
Hisashi Takasugi
Shigetaka Nishino
Akito Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898900191A external-priority patent/GB8900191D0/en
Priority claimed from GB898906575A external-priority patent/GB8906575D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI900035A0 publication Critical patent/FI900035A0/fi
Publication of FI900035A publication Critical patent/FI900035A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI900035A 1989-01-05 1990-01-04 Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI900035A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900191A GB8900191D0 (en) 1989-01-05 1989-01-05 Thiazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
GB898906575A GB8906575D0 (en) 1989-03-22 1989-03-22 Thiazole compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same

Publications (2)

Publication Number Publication Date
FI900035A0 FI900035A0 (fi) 1990-01-04
FI900035A true FI900035A (fi) 1990-07-06

Family

ID=26294803

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900035A FI900035A (fi) 1989-01-05 1990-01-04 Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (11)

Country Link
EP (1) EP0377457A1 (fi)
JP (1) JP3003148B2 (fi)
KR (1) KR900011765A (fi)
CN (1) CN1043936A (fi)
AU (1) AU631169B2 (fi)
CA (1) CA2007133A1 (fi)
FI (1) FI900035A (fi)
HU (1) HU205922B (fi)
IL (1) IL92939A0 (fi)
NO (1) NO900032L (fi)
PT (1) PT92786B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives
AU654125B2 (en) * 1991-03-07 1994-10-27 Hisamitsu Pharmaceutical Co., Inc. Novel diphenylthyazole derivative
DE69330823T2 (de) * 1992-02-13 2002-05-02 Merrell Pharmaceuticals Inc., Cincinnati Thiacyclische piperidinylderivate
DK0582164T3 (da) * 1992-07-31 1999-08-23 Bristol Myers Squibb Co Adenosin-genoptagelsesinhiberende derivater af diphenyloxazoler, -thiazoler og -imidazoler
TWI292316B (en) * 1999-10-11 2008-01-11 Sod Conseils Rech Applic Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
US20020183316A1 (en) * 2000-10-27 2002-12-05 Kevin Pan Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AR038966A1 (es) 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
JP2006506340A (ja) * 2002-08-09 2006-02-23 アストラゼネカ アクチボラグ 代謝調節型グルタミン酸受容体5のモジュレーターとしてのオキサジアゾール
JP4637578B2 (ja) 2002-08-09 2011-02-23 アストラゼネカ アクチボラグ 代謝調節型グルタミン酸受容体−5の調節因子としての1,2,4−オキサジアゾール類
CA2495179A1 (en) 2002-08-09 2004-02-19 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
US20040198800A1 (en) * 2002-12-19 2004-10-07 Geoffrey Allan Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
JP2006182648A (ja) * 2003-04-08 2006-07-13 Dai Ichi Seiyaku Co Ltd 7員複素環誘導体
KR20060005378A (ko) * 2003-04-21 2006-01-17 다이이찌 세이야꾸 가부시기가이샤 5원 복소환 유도체
TWI336697B (en) * 2003-09-19 2011-02-01 Solvay Pharm Bv Thiazole derivatives as cannabinoid receptor modulators
CA2543338A1 (en) * 2003-10-24 2005-05-06 Solvay Pharmaceuticals Gmbh Novel medical uses of compounds showing cb1-antagonistic activity and combination treatment involving said compounds
CA2585175A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
DE102009038123A1 (de) 2009-08-17 2011-02-24 Aicuris Gmbh & Co. Kg Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung
MA46540A (fr) * 2016-10-12 2019-08-21 Res Triangle Inst Agonistes du récepteur de l'apéline (apj) hétérocyclique et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496787A (en) * 1974-03-12 1978-01-05 Smith Kline French Lab Heteroalkylthioalkyl amidine derivatives
AU539801B2 (en) * 1980-10-14 1984-10-18 Pfizer Inc. Intermediates in the preparation of 2-guanidino-4- heteroarylthiazoles
DE3413755A1 (de) * 1984-04-12 1985-10-24 Basf Ag, 6700 Ludwigshafen Thiazolylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3621775A1 (de) * 1986-03-13 1988-01-07 Thomae Gmbh Dr K Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds

Also Published As

Publication number Publication date
HU205922B (en) 1992-07-28
FI900035A0 (fi) 1990-01-04
IL92939A0 (en) 1990-09-17
NO900032L (no) 1990-07-06
HUT54129A (en) 1991-01-28
JPH0327370A (ja) 1991-02-05
AU631169B2 (en) 1992-11-19
PT92786B (pt) 1996-01-31
NO900032D0 (no) 1990-01-04
HU900041D0 (en) 1990-03-28
CA2007133A1 (en) 1990-07-05
AU4768790A (en) 1990-07-12
PT92786A (pt) 1990-07-31
EP0377457A1 (en) 1990-07-11
CN1043936A (zh) 1990-07-18
JP3003148B2 (ja) 2000-01-24
KR900011765A (ko) 1990-08-02

Similar Documents

Publication Publication Date Title
FI922037A0 (fi) Uppsvaellbart, brandhaerdigt och elledande bestrykningsmaterial.
FI903845A0 (fi) Renininhibitorer, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI914144A0 (fi) Syrabestaendiga betongprodukter, speciellt svavelbetongroer och deras framstaellningfoerfarande.
FI915404A0 (fi) Endotermiska drivgaser, kompositioner och tillaempningar.
FI895047A0 (fi) Tienopyridiner, deras framstaellning, mellanprodukter och farmaceutiska sammansaettningar innehaollande dessa foereningar.
FI900313A0 (fi) Nya benzopyranderivat, deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI900035A0 (fi) Tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI874020A0 (fi) Tetrahydrokinolinderivat, foerfarande foer deras framstaellning, deras anvaendning och dessa innehaollande farmaceutiska preparat.
FI891061A (fi) Kondenserade kinolinfoereningar, kondenserade akridinfoereningar, foerfarande foer framstaellning daerav och karsinostatiska kompositioner innehaollande desamma.
FI904823A0 (fi) Karboxylsyraestrar, naemnda karboxylsyraestrar innehaollande flytande kompositioner och foerfaranden foer smoerjning av metalldelar.
FI902686A0 (fi) Foerfarande foer framstaellning av dubbelsidigt belagda bandtransportoerer, i synnerhet foer pappers- och textilmaskiner, och anordning foer utfoering av foerfarandet.
FI900682A0 (fi) Verktyg, paosaettningsmedel och ringanordning foer kedjor foer foerhindrande av glidning.
FI895286A0 (fi) Fenyloxipropanolaminer, deras framstaellning och terapeutiska anvaendning.
FI901461A0 (fi) Underrede foer raelsfoerbundna godsvagn, saerskilt foer tankvagnar och kapslade bulkgodsvagnar.
FI903630A0 (fi) Fluoranfoereningar, deras kristallina toluenaddukter, dessa innehaollande upptagningsmaterial och foerfarande foer deras framstaellning.
FI905753A (fi) Biologiskt nedbrytbara, vattenloesliga polykarboxylsyrakopolymerer, kompositioner innehaollande dylika kopolymerer, och foerfaranden foer anvaendning av saodana polymerer.
FI891891A0 (fi) Aminosyraestrar, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI893498A0 (fi) Anordning foer pressning, avvattning och filtrering.
FI904656A0 (fi) Fluoranfoereningar, foerfarande foer deras framstaellning och naemnda foerening innehaollande upptagningsmaterial.
FI901958A0 (fi) Reninhaemmande dipeptider, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
FI920474A0 (fi) Elektrofotografiskt framstaelld tryckplatta, med hydrofila tonade omraoden och oleofiliska otonade omraoden.
FI895997A0 (fi) Vaeggkonstruktion, saett och anordning foer bearbetning av vaeggstockar.
FI896212A0 (fi) Dubbningsfoerfarande, holkdubb och dubband.
FI893891A0 (fi) Sophaemtningsfoerfarande, griporgan och sopcontainer.
FI905087A0 (fi) Hydroxialkankarboxylsyra-derivat, deras framstaellning och anvaendning.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.